Cargando…
Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for regenerative therapy, disease modeling, and drug discovery. iPSCs allow for the production of limitless supply of patient-specific somatic cells that enable advancement in cardiovascular precision medicine. Over t...
Autores principales: | Paik, David T., Chandy, Mark, Wu, Joseph C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934989/ https://www.ncbi.nlm.nih.gov/pubmed/31871214 http://dx.doi.org/10.1124/pr.116.013003 |
Ejemplares similares
-
Elucidating effects of environmental exposure using human‐induced pluripotent stem cell disease modeling
por: Chandy, Mark, et al.
Publicado: (2022) -
Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery
por: Jang, Jiho, et al.
Publicado: (2012) -
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013) -
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery
por: Singh, Vimal K., et al.
Publicado: (2015) -
Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis
por: Lee, Jui-Hao, et al.
Publicado: (2018)